Gilead Sciences Navigates Strategic Transition as Market Awaits First Quarter Results and Tubulis Acquisition Closure
Gilead Sciences Inc. experienced a notable shift in market sentiment on Thursday as investors recalibrated their positions ahead of the company’s first-quarter earnings announcement, which is scheduled for release after…